TP53 and breast carcinoma: Although in vivo experiments provided validation for the gain-of-function properties of certain p53 missense mutants, they are limited in their usefulness as a specific model for studying mutant p53 function in human breast cancer, because these mice rarely if ever develop breast cancer.